Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Re: OK, try a cholinesterase inhibitor + AD » saralyn

Posted by Chairman_MAO on June 3, 2004, at 13:04:07

In reply to Re: Abilify is a MS that does not impair cognition, posted by saralyn on June 2, 2004, at 23:34:57


This is definitely in the realm of the experimental, but I think there's a lot of promise here. Cholinesterase inhibitors ENHANCE cognitive function and SUPRESS appetite. Try Aricept (mentioned here) or Reminyl + Wellbutrin, which is a good AD to use in bipolars. Alternatives for sparing cognitive function on the AD side abound, such as Parnate, desipramine, Strattera, etc.


Biol Psychiatry. 1999 Apr 15;45(8):959-64. Related Articles, Links


Donepezil in treatment-resistant bipolar disorder.

Burt T, Sachs GS, Demopulos C.

Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, USA.

BACKGROUND: A considerable percentage of patients with bipolar disorder do not respond or do not tolerate conventional treatment. Cholinesterase (ChE) inhibitors have been suggested to possess depressogenic and antimanic properties. METHODS: We report a case series of treatment-resistant bipolar patients (n = 11) to whom we administered the ChE inhibitor donepezil. Four patients met criteria for current manic episode, 5 for mixed episode, 1 for hypomanic episode, and 1 for major depressive episode. Donepezil was added to current medication on an openlabel basis. Ratings were based on a retrospective chart review. RESULTS: Of the 11 patients, 6 (54.5%) demonstrated marked improvement (improvement in CGI-S > or = 2), 3 (27.2%) demonstrated slight improvement, 1 did not respond, and 1 did not tolerate the medication. Among those patients who had marked improvement (i.e., responders, n = 6), improvement was observed within 2 weeks or less in 5 of them (83%). Patients experienced only minor side effects. CONCLUSIONS: These pilot data suggest the efficacy and safety of donepezil in the treatment of bipolar disorder. To our knowledge this is the first published report on the use of donepezil in the treatment of mood disorders. Controlled, randomized, double-blind studies are necessary to validate these preliminary observations.


Share
Tweet  

Thread

 

Post a new follow-up

Your message only Include above post


Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.

 

Start a new thread

 
Google
dr-bob.org www
Search options and examples
[amazon] for
in

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:Chairman_MAO thread:352826
URL: http://www.dr-bob.org/babble/20040602/msgs/353404.html